{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:33:27Z","timestamp":1787603607461,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic>Summary<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>Osteoporosis is a growing health burden requiring early risk assessment. In Saudi adults\u2009\u2265\u200960 years, FRAX scores with and without BMD showed minimal reclassification, with most shifts toward higher risk in younger groups. FRAX without BMD offers reliable stratification, supporting its use as a first-line screening tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional study included patients aged\u2009\u2265\u200960 years attending family medicine clinics at King Faisal Specialist Hospital &amp; Research Centre, Riyadh, undergoing DXA screening between January 1, 2016, and December 31, 2022. Baseline variables were age, sex, and BMI. FRAX variables assessed were family history of hip fracture (HF), prior fracture, smoking, glucocorticoid use, rheumatoid arthritis, and alcohol intake. Fracture risk was categorized using fixed and age-specific thresholds; differences in FRAX scores and reclassification patterns were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1,429 patients (mean age 68.07\u2009\u00b1\u20096.62 years), FRAX scores for major osteoporotic fracture (MOF) and HF) differed significantly with and without BMD. Subgroup analysis revealed no significant differences within specific age ranges (70\u201375 years for MOF and 60\u201375 years for HF) or among men across all age groups. Reclassification occurred in a small subset of patients, predominantly shifting toward higher-risk categories, particularly in younger age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FRAX without BMD provides robust risk stratification, with minimal impact on reclassification across age categories. These results highlight its utility as a primary screening strategy, whereas BMD assessment may be reserved for cases requiring further refinement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Osteoporosis is a skeletal disorder defined by reduced bone mineral density (BMD), commonly assessed by dual-energy X-ray absorptiometry (DXA). The Fracture Risk Assessment Tool (FRAX) estimates 10-year fracture risk. Saudi Arabia was recently included in FRAX, enabling population-specific risk estimation. Notably, FRAX can be applied with or without BMD, but limited Saudi data exist comparing both methods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11657-025-01638-w","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T10:16:30Z","timestamp":1764929790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Community-based evaluation of Saudi FRAX with and without BMD in Riyadh, Saudi Arabia"],"prefix":"10.1007","volume":"21","author":[{"given":"Muath","family":"Alkhunizan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Almasoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd","family":"Abdulmowla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoha","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Albedah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Elshaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"1638_CR1","doi-asserted-by":"publisher","unstructured":"Aspray TJ, Hill TR (2019) Osteoporosis and the Ageing Skeleton. In: Harris JR, Korolchuk VI, editors. Biochemistry and Cell Biology of Ageing: Part II Clinical Science [Internet]. Singapore: Springer Singapore; [cited 2025 Nov 8]. p. 453\u201376. (Subcellular Biochemistry; vol. 91). Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-981-13-3681-2_16","DOI":"10.1007\/978-981-13-3681-2_16"},{"issue":"1","key":"1638_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11657-018-0540-7","volume":"13","author":"M Zamani","year":"2018","unstructured":"Zamani M, Zamani V, Heidari B, Parsian H, Esmaeilnejad-Ganji SM (2018) Prevalence of osteoporosis with the World Health Organization diagnostic criteria in the Eastern Mediterranean Region: a systematic review and meta-analysis. Arch Osteoporos 13(1):129","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1638_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S et al (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16(1):609","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"1638_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82","journal-title":"Arch Osteoporos"},{"key":"1638_CR5","doi-asserted-by":"crossref","unstructured":"Alkhunizan M, Almasoud N, Munia Abdulmowla M, Khalid Z (2022) The Prevalence of Osteoporosis and Osteopenia Among Older Adults in a Community-Based Setting in Riyadh, Saudi Arabia. Cureus [Internet]. Dec 21 [cited 2025 Nov 8]; Available from: https:\/\/www.cureus.com\/articles\/123435-the-prevalence-of-osteoporosis-and-osteopenia-among-older-adults-in-a-community-based-setting-in-riyadh-saudi-arabia","DOI":"10.7759\/cureus.32765"},{"issue":"18","key":"1638_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18189831","volume":"18","author":"B Balkhi","year":"2021","unstructured":"Balkhi B, Alghamdi A, Alqusair S, Alotaibi B, AlRuthia Y, Alsanawi H et al (2021) Estimated direct medical cost of osteoporosis in Saudi Arabia: a single-center retrospective cost analysis. Int J Environ Res Public Health 18(18):9831","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"1638_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194(2):S3-11","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1638_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11657-015-0240-5","volume":"10","author":"M Sadat-Ali","year":"2015","unstructured":"Sadat-Ali M, Al-Dakheel DA, Azam MQ, Al-Bluwi MT, Al-Farhan MF, AlAmer HA et al (2015) Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia. Arch Osteoporos 10(1):37","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1638_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T S\u00f6zen","year":"2019","unstructured":"S\u00f6zen T, \u00d6z\u0131\u015f\u0131k L, \u00c7al\u0131k Ba\u015faran N (2019) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46\u201356","journal-title":"Eur J Rheumatol"},{"issue":"7","key":"1638_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1359\/JBMR.050304","volume":"20","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185\u20131194","journal-title":"J Bone Miner Res"},{"key":"1638_CR11","doi-asserted-by":"crossref","unstructured":"The Advisory Board of the National Osteoporosis Guideline Group, Kanis JA, Harvey NC, Cooper C, Johansson H, Od\u00e9n A, et al. (2016) A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25","DOI":"10.1007\/s11657-016-0278-z"},{"key":"1638_CR12","doi-asserted-by":"crossref","unstructured":"The National Osteoporosis Guideline Group (NOGG), Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, et al. (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43","DOI":"10.1007\/s11657-017-0324-5"},{"issue":"sup2","key":"1638_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/13697137.2015.1092342","volume":"18","author":"JA Kanis","year":"2015","unstructured":"Kanis JA, Harvey NC, Johansson H, Od\u00e9n A, Leslie WD, McCloskey EV (2015) FRAX and fracture prediction without bone mineral density. Climacteric 18(sup2):2\u20139","journal-title":"Climacteric"},{"issue":"2","key":"1638_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000509","volume":"3","author":"A Marques","year":"2017","unstructured":"Marques A, Lucas R, Sim\u00f5es E, Verstappen SMM, Jacobs JWG, Da Silva JAP (2017) Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study. RMD Open 3(2):e000509","journal-title":"RMD Open"},{"issue":"1","key":"1638_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-011-9544-7","volume":"90","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX\u00ae with and without bone mineral density. Calcif Tissue Int 90(1):1\u201313","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1638_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00756-x","volume":"15","author":"R Rajan","year":"2020","unstructured":"Rajan R, Paul J, Cherian KE, Asha HS, Kapoor N, Paul TV (2020) FRAX\u00ae with or without BMD and TBS predicts fragility fractures in community-dwelling rural southern Indian postmenopausal women. Arch Osteoporos 15(1):82","journal-title":"Arch Osteoporos"},{"issue":"2018","key":"1638_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4636028","volume":"4","author":"RS Prawiradilaga","year":"2018","unstructured":"Prawiradilaga RS, Gunmalm V, Lund-Jacobsen T, Helge EW, Br\u00f8ns C, Andersson M et al (2018) FRAX calculated without BMD resulting in a higher fracture risk than that calculated with BMD in women with early breast cancer. J Osteoporos 4(2018):1\u20136","journal-title":"J Osteoporos"},{"issue":"1","key":"1638_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11657-021-01024-2","volume":"16","author":"NM Al-Daghri","year":"2021","unstructured":"Al-Daghri NM, Sabico S, Al-Saleh Y, Sulimani R, Aljohani NJ, Sheshah E et al (2021) The application of FRAX in Saudi Arabia. Arch Osteoporos 16(1):166","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1638_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11657-023-01242-w","volume":"18","author":"Y Al-Saleh","year":"2023","unstructured":"Al-Saleh Y, Sulimani R, Sabico S, Alshahrani FM, Fouda MA, Almohaya M et al (2023) Diagnosis and management of osteoporosis in Saudi Arabia: 2023 key updates from the Saudi Osteoporosis Society. Arch Osteoporos 18(1):75","journal-title":"Arch Osteoporos"},{"issue":"5","key":"1638_CR20","first-page":"40","volume":"34","author":"RC Simpkins","year":"2017","unstructured":"Simpkins RC, Downs TN, Lane MT (2017) FRAX prediction with and without bone mineral density testing. Fed Pract Health Care Prof VA DoD PHS 34(5):40\u201343","journal-title":"Fed Pract Health Care Prof VA DoD PHS"},{"issue":"5","key":"1638_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4158\/EP12416.OR","volume":"19","author":"RK Gadam","year":"2013","unstructured":"Gadam RK, Schlauch K, Izuora KE (2013) Frax prediction without BMD for assessment of osteoporotic fracture risk. Endocr Pract 19(5):780\u2013784","journal-title":"Endocr Pract"},{"key":"1638_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bone.2015.02.013","volume":"75","author":"JW Kim","year":"2015","unstructured":"Kim JW, Koh JM, Park JH, Chang JS (2015) Validation of FRAX without BMD: an age-related analysis of the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010). Bone 75:27\u201331","journal-title":"Bone"},{"issue":"6","key":"1638_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4103\/ijem.IJEM_412_18","volume":"22","author":"A Asirvatham","year":"2018","unstructured":"Asirvatham A, Balachandran K, Kannan S, Balasubramaniam S, Mahadevan S (2018) FRAX first \u2013 pragmatic approach in resource poor settings. Indian J Endocrinol Metab 22(6):757","journal-title":"Indian J Endocrinol Metab"},{"key":"1638_CR24","doi-asserted-by":"crossref","unstructured":"U.S. Preventive Services Task Force*. (2011) Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 154(5):356\u201364","DOI":"10.7326\/0003-4819-154-5-201103010-00307"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01638-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01638-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01638-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T10:16:31Z","timestamp":1764929791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01638-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1638"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01638-w","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were in accordance with institutional\/national ethical standards and the 1964 Helsinki Declaration, including later amendments or comparable standards. The study was approved by the Institutional Review Board of KFSH&RC (RAC#2221240). All patient data were kept confidential, and privacy was strictly maintained. For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Muath Alkhunizan, Nouf Almasoud, Majd Abdulmowla, Zoha Khalid, Norah Albedah, and Mohammad Elshaker declare no real, potential, or perceived conflicts of interest, including financial, professional, or personal relationships that could influence the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"6"}}